A clinical trial involving gonadorelin has been updated with a status change on October 2, 2026. The study, registered as NCT01511588 and titled "Hormonal Regulation of Puberty and Fertility," is now listed as COMPLETED on ClinicalTrials.gov. No phase information was provided in the record for this study. The update reflects only the change in trial status and does not include any reported outcomes or findings. Completion of a trial indicates that the study has concluded its planned activities, but it does not by itself indicate what, if any, results were observed. No efficacy or safety data were included with this status update. Readers should not assume any conclusions about gonadorelin's effects based solely on this status change. Gonadorelin remains an approved compound, and this update pertains specifically to the referenced trial record. Further details, including any eventual results postings, would be reflected in future updates to the same ClinicalTrials.gov record. For more background on gonadorelin, readers can consult the compound overview.
Gonadorelin Trial "Hormonal Regulation of Puberty and Fertility" Marked Completed
See the full gonadorelin overview
Source: https://clinicaltrials.gov/study/NCT01511588